DP D’Cruz

501 total citations
9 papers, 372 citations indexed

About

DP D’Cruz is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, DP D’Cruz has authored 9 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 4 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in DP D’Cruz's work include Systemic Lupus Erythematosus Research (6 papers), Vasculitis and related conditions (3 papers) and Otitis Media and Relapsing Polychondritis (2 papers). DP D’Cruz is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Vasculitis and related conditions (3 papers) and Otitis Media and Relapsing Polychondritis (2 papers). DP D’Cruz collaborates with scholars based in United Kingdom, Belgium and United States. DP D’Cruz's co-authors include Simon Cooper, Z. John Zhong, MA Dooley, Frédéric Houssiau, Anca Askanase, Cynthia Aranow, EM Ginzler, RJ Davies, Myles Lewis and Ralph Wedgwood and has published in prestigious journals such as Lupus and Scandinavian Journal of Rheumatology.

In The Last Decade

DP D’Cruz

9 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DP D’Cruz United Kingdom 7 324 195 123 108 44 9 372
EM Ginzler United States 6 259 0.8× 152 0.8× 99 0.8× 59 0.5× 29 0.7× 8 332
H M Hazevoet Netherlands 8 324 1.0× 162 0.8× 76 0.6× 79 0.7× 27 0.6× 9 455
Ziqian Wang China 12 315 1.0× 157 0.8× 61 0.5× 22 0.2× 35 0.8× 31 402
Donatella Ventura Italy 6 247 0.8× 104 0.5× 24 0.2× 93 0.9× 43 1.0× 11 316
DD Gladman Canada 12 290 0.9× 192 1.0× 57 0.5× 22 0.2× 20 0.5× 19 341
E. Mortensen Norway 9 161 0.5× 144 0.7× 77 0.6× 79 0.7× 10 0.2× 20 358
Risto Perich-Campos Peru 10 248 0.8× 139 0.7× 41 0.3× 28 0.3× 11 0.3× 34 305
Ka Lung Yu China 7 319 1.0× 200 1.0× 36 0.3× 20 0.2× 32 0.7× 9 351
Benjamin Empson United Kingdom 2 204 0.6× 113 0.6× 61 0.5× 16 0.1× 17 0.4× 2 267
Hector Arbillaga Canada 9 312 1.0× 165 0.8× 61 0.5× 13 0.1× 15 0.3× 11 344

Countries citing papers authored by DP D’Cruz

Since Specialization
Citations

This map shows the geographic impact of DP D’Cruz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DP D’Cruz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DP D’Cruz more than expected).

Fields of papers citing papers by DP D’Cruz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DP D’Cruz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DP D’Cruz. The network helps show where DP D’Cruz may publish in the future.

Co-authorship network of co-authors of DP D’Cruz

This figure shows the co-authorship network connecting the top 25 collaborators of DP D’Cruz. A scholar is included among the top collaborators of DP D’Cruz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DP D’Cruz. DP D’Cruz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bézanahary, H., et al.. (2014). Increased risk of vascular complications in Takayasu’s arteritis patients with positive lupus anticoagulant. Scandinavian Journal of Rheumatology. 44(3). 211–214. 17 indexed citations
2.
3.
Dooley, MA, Frédéric Houssiau, Cynthia Aranow, et al.. (2012). Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE. Lupus. 22(1). 63–72. 203 indexed citations
4.
Matar, Hosam E., et al.. (2012). Correlation of 24-hour urinary protein quantification with spot urine protein:creatinine ratio in lupus nephritis. Lupus. 21(8). 836–839. 8 indexed citations
5.
6.
D’Cruz, DP, et al.. (2009). The Euro-Lupus Nephritis Trial: the development of the sequential treatment protocol. Lupus. 18(10). 875–877. 14 indexed citations
7.
Davies, RJ, et al.. (2006). Antiphospholipid (Hughes) syndrome and atheroma. Lupus. 15(11_suppl). 55–58. 5 indexed citations
8.
D’Cruz, DP. (2005). Mycophenolate mofetil in systemic vasculitis. Lupus. 14(1_suppl). 55–57. 3 indexed citations
9.
D’Cruz, DP. (2005). Mycophenolate mofetil in systemic vasculitis. Lupus. 14(3_suppl). 55–57. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by EM Ginzler Breakdown of academic impact, for papers by H M Hazevoet Breakdown of academic impact, for papers by Ziqian Wang Breakdown of academic impact, for papers by Donatella Ventura Breakdown of academic impact, for papers by DD Gladman Breakdown of academic impact, for papers by E. Mortensen Breakdown of academic impact, for papers by Risto Perich-Campos Breakdown of academic impact, for papers by Ka Lung Yu Breakdown of academic impact, for papers by Benjamin Empson Breakdown of academic impact, for papers by Hector Arbillaga
Rankless by CCL
2026